TR200003084T2 - Paroxetine askorbat - Google Patents

Paroxetine askorbat

Info

Publication number
TR200003084T2
TR200003084T2 TR2000/03084T TR200003084T TR200003084T2 TR 200003084 T2 TR200003084 T2 TR 200003084T2 TR 2000/03084 T TR2000/03084 T TR 2000/03084T TR 200003084 T TR200003084 T TR 200003084T TR 200003084 T2 TR200003084 T2 TR 200003084T2
Authority
TR
Turkey
Prior art keywords
paroxetine ascorbate
paroxetine
ascorbate
useful
treatment
Prior art date
Application number
TR2000/03084T
Other languages
English (en)
Turkish (tr)
Inventor
Urquhart Michael
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR200003084T2 publication Critical patent/TR200003084T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/03084T 1998-04-25 1999-04-23 Paroxetine askorbat TR200003084T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
TR200003084T2 true TR200003084T2 (tr) 2001-02-21

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03084T TR200003084T2 (tr) 1998-04-25 1999-04-23 Paroxetine askorbat

Country Status (20)

Country Link
EP (1) EP1089995A1 (xx)
JP (1) JP2002513019A (xx)
KR (1) KR20010042977A (xx)
CN (1) CN1297448A (xx)
AP (1) AP2000001963A0 (xx)
AU (1) AU3618499A (xx)
BG (1) BG104940A (xx)
BR (1) BR9909868A (xx)
CA (1) CA2330055A1 (xx)
EA (1) EA200001104A1 (xx)
GB (1) GB9808896D0 (xx)
HU (1) HUP0102116A3 (xx)
ID (2) ID26083A (xx)
IL (1) IL139081A0 (xx)
NO (1) NO20005352L (xx)
PL (1) PL343677A1 (xx)
SK (1) SK15912000A3 (xx)
TR (1) TR200003084T2 (xx)
WO (1) WO1999055698A1 (xx)
ZA (1) ZA200005912B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
EP2272501B1 (en) * 2002-01-09 2013-03-20 Emisphere Technologies, Inc. Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
CN110607554B (zh) * 2018-10-30 2024-03-22 中国科学院化学研究所 一种制备药物或药物中间体单晶或无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
ID26654A (id) 2001-01-25
HUP0102116A2 (hu) 2002-05-29
SK15912000A3 (sk) 2001-04-09
KR20010042977A (ko) 2001-05-25
ID26083A (id) 2000-11-23
BR9909868A (pt) 2000-12-19
BG104940A (bg) 2001-09-28
EP1089995A1 (en) 2001-04-11
NO20005352D0 (no) 2000-10-24
IL139081A0 (en) 2001-11-25
WO1999055698A1 (en) 1999-11-04
GB9808896D0 (en) 1998-06-24
JP2002513019A (ja) 2002-05-08
CN1297448A (zh) 2001-05-30
EA200001104A1 (ru) 2001-04-23
ZA200005912B (en) 2001-12-19
NO20005352L (no) 2000-10-24
AU3618499A (en) 1999-11-16
PL343677A1 (en) 2001-08-27
HUP0102116A3 (en) 2002-12-28
AP2000001963A0 (en) 2000-12-31
CA2330055A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
TR200000059T2 (tr) Piridin türevleri
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
ATE264863T1 (de) 28-epirapaloge
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
PT882021E (pt) Novas fenantridinas
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
CO4970820A1 (es) Sal de bisulfato del inhibidor de la vih-proteasa
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
RS50071B (sr) Novi oblik soli pantoprazola
DE60139466D1 (de) Behandlung von diabetes
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DK1204659T3 (da) Serotonerge benzofuraner
BR0012921A (pt) Compostos calcilìticos
TR200003084T2 (tr) Paroxetine askorbat
TR200002939T2 (tr) Paroksetin maleat
NO20005548D0 (no) Mykobakterieinhibitorer
ES2185605T3 (es) 2,3-dihidro-1h-5,9-dioxaciclohepta (f) inden-7-onas 1,2-sustituidas y benzo (b) (1,4)dioxepin-3 onas 7-sustituidas.
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
IT1305242B1 (it) Preparatore di mazzi di pelli.